IN VITRO TEST DETERMINATION OF SGPT(ALT)

Nadh Oxidation/nad Reduction, Alt/sgpt

CLINICAL DATA, INC.

The following data is part of a premarket notification filed by Clinical Data, Inc. with the FDA for In Vitro Test Determination Of Sgpt(alt).

Pre-market Notification Details

Device IDK854186
510k NumberK854186
Device Name:IN VITRO TEST DETERMINATION OF SGPT(ALT)
ClassificationNadh Oxidation/nad Reduction, Alt/sgpt
Applicant CLINICAL DATA, INC. 1172 COMMONWEALTH AVE. Boston,  MA  02134
ContactIsrael M Stein
CorrespondentIsrael M Stein
CLINICAL DATA, INC. 1172 COMMONWEALTH AVE. Boston,  MA  02134
Product CodeCKA  
CFR Regulation Number862.1030 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1985-10-15
Decision Date1985-12-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.